Next Article in Journal
Production Characteristics of Miscanthus (Mischantus × Giganteus Greef et Deu) under Agroecological Conditions of Serbia
Previous Article in Journal
Organic Plant Bio-Stimulant for Early, Enhanced and Healthy Growth of Chilli Seedlings
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Hybrid Molecules Based on Fullerene C60 and Spiropyrans as a Promising Approach to the Creation of Anticancer Drugs †

Institute of Petrochemistry and Catalysis of RAS, 450075 Ufa, Russia
*
Author to whom correspondence should be addressed.
Presented at the 25th International Electronic Conference on Synthetic Organic Chemistry, 15–30 November 2021; Available online: https://ecsoc-25.sciforum.net/.
Chem. Proc. 2022, 8(1), 93; https://doi.org/10.3390/ecsoc-25-11656
Published: 13 November 2021

Abstract

:
In this work, we present a novel spiropyran–containing photochromic pyrrolidinofullerene as a promising agent for the photodynamic therapy of cancer.

1. Introduction

Cancer is one of the leading causes of mortality among the working–age population around the world. To date, a huge number of chemotherapeutic drugs have beenused to treat oncological diseases, but most of the known and widely used anticancer drugs in medical practice are extremely toxic and non–selective. One of the possible approaches to solving this problem is the use of photoactivated molecules, which, under the action of light, can isomerize and pass from an inactive form to an active one in certain targets.
Currently, the literature describes a wide range of different classes of compounds that exhibit antitumor activity under the influence of UV light [1,2,3]: dithienylethenes [4], fulgimides [4], azobenzene [5], etc. [6,7,8,9].
The cytotoxicity of spiropyrans and their photoinduced merocyanine forms is poorly studied due to the limited number of studies and therather narrow range of photochromic molecules, which does not allow us to revealthe pattern of the structure–cytotoxic activity. Therefore, to date, the only successful application of photoswitching of the cytotoxicity of spirophotochromes in relation to cancer cells is the work [10], devoted to the synthesis of water–soluble spiropyran, which penetrates into Hek293 cells without showing a cytotoxic effect, as long as under the influence of thermostable UV light, the form of spiropyran is not isomerized to merocyanine.
Due to their structural features, spiropyrans penetrate poorly through cell membranes. Taking this into account, we assumed that the chemical binding of spiropyrans with fullerenes can contribute not only to the better penetration of a new hybrid molecule into a cancer cell, but also to an increase in cytotoxicity due to the unique transport properties of the original molecule of the carbon cluster.
In order to confirm the proposed idea, in this work, we carried out the synthesis of previously undescribed pyrrolidinofullerenes containing spiropyran addends.

2. Results and Discussion

As the main method for the preparation of pyrrolidinofullerenes, we chose the Prato reaction based on 1,3–dipolar cycloaddition to the carbon cluster of azomethine ylides generated in situ throughthe interaction of an aldehyde with sarcosine. Thus, the reaction of C60 fullerene with spiropyrans 1–3 in the presence of sarcosine leads to the formation of pyrrolidinofullerenes 4–6 with a yield of 56–62% (Figure 1). The choice of these starting monomers is due to several reasons. The presence of the NO2-group, as shown in our previous work [11], promotes the manifestation of the photochromic properties of the new hybrid molecule. The use of alkyl bromide substituents of various lengths at the nitrogen atom of the indole fragment makes it possible to establish the effect of the arrangement of the ammonium group in the hybrid molecule on the water–soluble properties of the latter.
At present, physicochemical studies of the photochromic properties of new hybrid molecules are being carried out in order to identify the most promising samples for the subsequent study of their cytotoxic activity.

3. Materials and Methods

All reactions were performed under an argon atmosphere and in anhydrous solvent. The solvents and reagents were dried or refined according to the literature procedures. Commercially available C60 fullerene (99.5% pure, Sigma–Aldrich) was used. The reaction products were analyzed on a HPLC chromatograph Shimadzu SPD–20A (Japan). The 1H and 13C NMR spectra were run on a Bruker Avance-500 spectrometer. The mass spectra were obtained on an UltraFlex III TOF/TOF (Bruker Daltonik GmbH, Bremen, Germany) operating in linear (TOF) and reflection (TOF/TOF) positive and negative ion modes.
Procedure for the synthesis of pyrrolidinofullerenes 4–6.
To a solution of 0.1 g (0.139 mmol) C60 in 15 mL chlorobenzene, 0.025 g (0.278 mmol) sarcosine and 0.695 mmol corresponding spiropyran aldehyde 1–3 were added. The resulting mixture was heated for two hours at 100–110 °C. The reaction products 4–6 and the starting fullerene C60 were separated usingthe semi-preparative HPLC, and the eluent was toluene.
Procedure for the synthesis of pyrrolidinofullerenes 7–9.
Trimethylamine–EtOH solution (0.5 mL, 35% Et3N in EtOH) was added to a flask containing compounds 4–6 (50 mg, 0.04 mmol) in 5 mL toluene, and the solution was stirred at rt for 24 h in darkness. The formed precipitate was collected by filtration and washed with EtOH (90% yield).

4. Conclusions

Under the conditions of the Prato reaction, the synthesis of new pyrrolidinofullerenes containing spiropyran addends, potentially possessing light–regulated cytotoxic activity, was carried out.

Author Contributions

Conceptualization, data curation, synthetic investigation, writing–original draft, and review and editing, A.A.K., L.L.K. and A.R.T.; supervision: U.M.D. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the Russian Science Foundation (Project No. 21-73-10112) and approved plans for research projects at the IPC RAS State Registration No. AAAA-A19-119022290008-6 (2019-2021).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data available on request.

Acknowledgments

The structural studies of the synthesized compounds were performed with the use of Collective Usage Centre “Agidel” at the Institute of Petrochemistry and Catalysis of RAS.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mayer, G.; Heckel, A. BiologicallyActiveMoleculeswitha“LightSwitch”. Angew. Chem. Int. Ed. 2006, 45, 4900–4921. [Google Scholar] [CrossRef] [PubMed]
  2. Young, D.D.; Deiters, A. Photochemicalcontrolofbiologicalprocesses. Org. Biomol. Chem. 2007, 5, 999–1005. [Google Scholar] [CrossRef] [PubMed]
  3. Sortino, S. Photoactivated nanomaterials for biomedical release applications. J. Mater. Chem. 2012, 22, 301–318. [Google Scholar] [CrossRef]
  4. Wutz, D.; Gluhacevic, D.; Chakrabarti, A.; Schmidtkunz, K.; Robaa, D.; Erdmann, F.; Romier, C.; Sippl, W.; Jung, M.; König, B. Photochromic histone deacetylase inhibitors based on dithienylethenes and fulgimides. Org. Biomol. Chem. 2017, 15, 4882–4896. [Google Scholar] [CrossRef] [PubMed]
  5. Wang, X.; Liang, X. Azobenzene-modified antisense oligonucleotides for site-specific cleavage of RNA with photocontrollable property. RSC Adv. 2016, 6, 93398–93402. [Google Scholar] [CrossRef]
  6. Borowiak, M.; Nahaboo, W.; Reynders, M.; Nekolla, K.; Jalinot, P.; Hasserodt, J.; Rehberg, M.; Delattre, M.; Zahler, S.; Vollmar, A.; et al. Photoswitchable inhibitors of microtubule dynamics optically control mitosis and cell death. Cell 2015, 162, 403–411. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Sheldon, J.E.; Dcona, M.M.; Lyons, C.E.; Hackett, J.C.; Hartman, M.C. Photoswitchable anticancer activity via trans–cis isomerization of a combretastatin A-4 analog. Org. Biomol. Chem. 2016, 14, 40–49. [Google Scholar] [CrossRef] [PubMed]
  8. Scherbakov, A.M.; Salnikova, D.I.; Mikhailova, A.; Balakhonov, R.; Yadykov, A.; Shirinian, V. 47P Evaluation of combinations of photoswitchable novel combretastatin A-4 analogues with chemotherapy drugs and metformin. Ann. Oncol. 2021, 32, S19. [Google Scholar] [CrossRef]
  9. Weng, T.; Qiu, X.; Wang, J.; Li, Z.; Bian, J. Recent discovery of indoleamine-2, 3-dioxygenase 1 inhibitors targeting cancer immunotherapy. Eur. J. Med. Chem. 2018, 143, 656–669. [Google Scholar] [CrossRef] [PubMed]
  10. Nilsson, J.R.; Li, S.; Önfelt, B.; Andréasson, J. Light-induced cytotoxicity of a photochromic spiropyran. Chem. Commun. 2011, 47, 11020–11022. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Tuktarov, A.R.; Khuzin, A.A.; Tulyabaev, A.R.; Venidictova, O.V.; Valova, T.M.; Barachevsky, V.A.; Khalilov, L.M.; Dzhemilev, U.M. Synthesis, structure and photochromic properties of hybrid molecules based on fullerene C 60 and spiropyrans. RSC Adv. 2016, 6, 71151–71155. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Synthesis of pyrrolidinofullerenes containing spiropyrane moieties.
Figure 1. Synthesis of pyrrolidinofullerenes containing spiropyrane moieties.
Chemproc 08 00093 g001
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Khuzin, A.A.; Khuzina, L.L.; Tuktarov, A.R.; Dzhemilev, U.M. Hybrid Molecules Based on Fullerene C60 and Spiropyrans as a Promising Approach to the Creation of Anticancer Drugs. Chem. Proc. 2022, 8, 93. https://doi.org/10.3390/ecsoc-25-11656

AMA Style

Khuzin AA, Khuzina LL, Tuktarov AR, Dzhemilev UM. Hybrid Molecules Based on Fullerene C60 and Spiropyrans as a Promising Approach to the Creation of Anticancer Drugs. Chemistry Proceedings. 2022; 8(1):93. https://doi.org/10.3390/ecsoc-25-11656

Chicago/Turabian Style

Khuzin, Artur A., Liliya L. Khuzina, Airat R. Tuktarov, and Usein M. Dzhemilev. 2022. "Hybrid Molecules Based on Fullerene C60 and Spiropyrans as a Promising Approach to the Creation of Anticancer Drugs" Chemistry Proceedings 8, no. 1: 93. https://doi.org/10.3390/ecsoc-25-11656

Article Metrics

Back to TopTop